Improving imaging techniques for detecting eye changes in neurodegenerative diseases
Official title: Achieving specificity in imaging neurodegeneration with visible light Optical Coherence Tomography
Funded at New York University School of Medicine · NIH-11096252 · Data updated 2026-11-12
This study is working on a new way to take clearer pictures of the retina to help doctors better understand how diseases like Alzheimer's and Parkinson's affect vision, which could lead to better ways to track and treat these conditions.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | New York University School of Medicine NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project start | September 15, 2024 |
| Project end | September 14, 2025 |
| Funding year | 2024 |
| Award (this year) | $1,599,999 |
| NIH project number | 1OT2OD038130-01 |
| Project ID | NIH-11096252 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research include individuals diagnosed with Alzheimer's disease or Parkinson's disease who are experiencing visual system changes.
✕Less likely to help
Patients with neurodegenerative diseases who do not exhibit any ocular symptoms or changes may not benefit from this research.
What this research studies
This research focuses on enhancing imaging technology to better visualize changes in the retina associated with neurodegenerative diseases like Alzheimer's and Parkinson's. By developing a new type of optical coherence tomography (OCT) that uses visible light, the researchers aim to achieve higher resolution images of the retina, which can reveal important biomarkers for disease progression. The study will also incorporate machine learning tools to analyze the imaging data, providing a more detailed understanding of how these diseases affect the visual system. This could lead to improved monitoring and treatment strategies for patients.
Why it matters
Potential benefit: If successful, this research could lead to earlier detection and better management of neurodegenerative diseases through improved retinal imaging.
How similar studies have gone: Previous research has shown promise in using advanced imaging techniques for understanding neurodegenerative diseases, indicating that this approach could yield valuable insights.
Where this research is happening
-
New York University School of Medicine
New York, United States Active
Researchers
- Principal investigator: Srinivasan, Vivek Jay — New York University School of Medicine
- Study coordinator: Srinivasan, Vivek Jay
Related research
Other NIH-funded projects on the same topics.
-
Actions to Decrease Disparities in Blood Pressure Control for Blacks
Aiming to help Black patients manage high blood pressure by using nurses, community health workers, and home monitoring in real-world clinics.
-
Blood-based markers to identify lung cancer risk in never-smokers
A researchers team at NYU School of Medicine is testing blood tests that might flag higher lung cancer risk in people who have never smoked, helping decide who might need screening.
-
Oxytocin's effect on social brain function in autistic adults
A group at NYU School of Medicine studies how oxytocin affects social thinking and brain activity in adults with autism.
-
COVID-19 healthcare disruptions and heart health inequities in NYC adults with multiple conditions
This project looks at how COVID-19-related gaps in care affected heart health in adults with several chronic conditions in New York City.
-
Connecting TDP-43 Pathology to Molecular Profiles in Neurodegeneration
This grant explores how specific molecular patterns in brain tissue relate to ALS and Alzheimer’s disease features, aiming to improve understanding of disease subtypes and progression.
-
INOCA-mobile heart rehab for angina and breathlessness
A mobile health-based cardiac rehabilitation program is being tested to help people with INOCA feel better and move more.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.